Krilogy Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$663K Buy
1,715
+420
+32% +$156K 0.02% 536
2026
Q1
$409K Sell
1,295
-1,176
-48% -$387K 0.01% 641
2025
Q4
$931K Buy
2,471
+657
+36% +$222K 0.03% 364
2025
Q3
$577K Buy
+1,814
New +$564K 0.02% 481
2018
Q4
Sell
-284
Closed -$78K 282
2018
Q3
$78K Buy
+284
New +$73.7K 0.02% 253
2018
Q2
Sell
-161
Closed -$35K 290
2018
Q1
$35K Hold
161
0.01% 366
2017
Q4
$36K Hold
161
0.01% 361
2017
Q3
$31K Sell
161
-687
-81% -$131K 0.01% 413
2017
Q2
$160K Buy
+848
New +$152K 0.04% 157

Other funds holding ELV

Krilogy Financial's ELV Position: Q2 2026 in Review

Krilogy Financial increased its Elevance Health (ELV) stake by 32% in Q2 2026, buying an estimated $156K and bringing the position to 1,715 shares worth $663K. The position accounts for 0.02% of the portfolio, ranked #536.

Krilogy Financial first reported a position in ELV in Q2 2017 and has held it in 9 quarters since. The position peaked at $931K in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Krilogy Financial held 1,715 shares of Elevance Health worth $663K as of Q2 2026.
  • Krilogy Financial bought 420 Elevance Health shares in Q2 2026, an estimated $156K.
  • Elevance Health made up 0.02% of Krilogy Financial's portfolio in Q2 2026, its #536 holding.
  • Krilogy Financial first reported a position in Elevance Health in Q2 2017 and has held it in 9 quarters since.
  • Krilogy Financial's Elevance Health position peaked at $931K in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.